Q1 FY27 snapshot
Announcement Date11-Aug-26
Revenue (Top Line)₹ 8017 Cr
Net Profit (Bottom Line)₹ 990 Cr
Earnings Per Share (EPS)₹9.42
Expenses₹ 6088 Cr
Net profit margin (calculated)12.3%
Zydus Lifescience (ZYDUSLIFE) Quarterly Results: Q1 FY27
Quick answer: Zydus Lifescience (NSE: ZYDUSLIFE) reported Q1 FY27 revenue of ₹ 8017 Cr and net profit of ₹ 990 Cr, with earnings per share (EPS) of ₹9.42, announced on 11-Aug-26.
That works out to a net profit margin of about 12.3% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Zydus Lifescience's Q1 FY27 results
Revenue of ₹ 8017 Cr is what Zydus Lifescience earned before costs. Net profit of ₹ 990 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 12.3%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
Zydus Lifescience results FAQs
What were Zydus Lifescience's Q1 FY27 results?
Zydus Lifescience (NSE: ZYDUSLIFE) reported Q1 FY27 revenue of ₹ 8017 Cr and net profit of ₹ 990 Cr, with earnings per share (EPS) of ₹9.42, announced on 11-Aug-26.
What is Zydus Lifescience's EPS for Q1 FY27?
Zydus Lifescience's earnings per share for Q1 FY27 was ₹9.42. EPS is net profit divided by the number of outstanding shares.
When did Zydus Lifescience announce its Q1 FY27 results?
Zydus Lifescience announced its Q1 FY27 results on 11-Aug-26.
What is Zydus Lifescience's net profit margin?
On the reported figures, Zydus Lifescience's Q1 FY27 net profit margin is about 12.3% (net profit ÷ revenue).